Accepted for/Published in: JMIR Mental Health
Date Submitted: Aug 3, 2019
Open Peer Review Period: Aug 2, 2019 - Aug 12, 2019
Date Accepted: Sep 23, 2019
(closed for review but you can still tweet)
Prognosis Prediction using Therapeutic Agreement of Videoconference-Delivered Cognitive Behavioral Therapy: Retrospective Secondary Analysis of a Single-Arm Pilot Trial
ABSTRACT
Background:
The therapist-patient therapeutic alliance is known as an important factor in cognitive behavioral therapy (CBT). However, findings by previous studies for obsessive-compulsive disorder (OCD), panic disorder (PD) and social anxiety disorder (SAD) have not been consistent on whether this alliance provides symptomatic improvements.
Objective:
This study investigated predictors of symptom improvement in patients receiving CBT via videoconference.
Methods:
Twenty-nine patients who performed the previous clinical trial participated in current study. Therapeutic Alliance and clinical background in patients with OCD, PD, and SAD were measured at first session or 8th, which were calculated by multiple regression analysis to estimate the impact on therapeutic response percentage change.
Results:
The multiple regression analysis showed that among the independent variables, only patients’ agreement in therapeutic alliance remained; other variables were a best fit for the excluded model (P = .002). The result show patients’ agreement on therapeutic goal and task explains the prognosis: the normalization factor β was 0.540 (SE = 32.73, 95% CI = 1.23 to 5.17, P = .002), the adjusted R-squared was 0.266.
Conclusions:
Patients' agreement on therapeutic goal and task predicts improvement after CBT via videoconference.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.